Studio Investment Management LLC Purchases 467 Shares of The Clorox Company $CLX

Studio Investment Management LLC boosted its position in The Clorox Company (NYSE:CLX) by 9.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,447 shares of the company’s stock after purchasing an additional 467 shares during the quarter. Studio Investment Management LLC’s holdings in Clorox were worth $654,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Simplicity Wealth LLC boosted its position in shares of Clorox by 157.3% during the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after buying an additional 11,198 shares during the last quarter. Raymond James Financial Inc. boosted its position in Clorox by 15.6% in the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after purchasing an additional 36,352 shares during the last quarter. OneDigital Investment Advisors LLC purchased a new position in Clorox in the first quarter worth about $247,000. Cornerstone Wealth Group LLC boosted its position in Clorox by 19.0% in the first quarter. Cornerstone Wealth Group LLC now owns 25,582 shares of the company’s stock worth $3,767,000 after purchasing an additional 4,085 shares during the last quarter. Finally, Alpine Bank Wealth Management purchased a new position in Clorox in the first quarter worth about $478,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CLX. UBS Group decreased their price objective on Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. Wells Fargo & Company decreased their price objective on Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 25th. Barclays decreased their target price on Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research note on Tuesday, September 30th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. Finally, Morgan Stanley dropped their target price on Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $130.20.

Clorox Trading Up 0.3%

Shares of NYSE:CLX opened at $119.94 on Wednesday. The business’s 50-day moving average is $121.50 and its 200 day moving average is $127.36. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The firm has a market capitalization of $14.61 billion, a P/E ratio of 18.40, a P/E/G ratio of 0.99 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. Clorox’s dividend payout ratio is currently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.